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Abstract
Background: Salmonella enterica subsp. enterica is one of the leading food-borne pathogens in the USA and
European countries. Outcome of human Salmonella serotype Typhimurium infections ranges from mild self-limiting
diarrhoea to severe diarrhoea that requires hospitalization. Increased knowledge of the mechanisms that are
responsible for causing infection and especially the severity of infection is of high interest.
Results: Strains were selected from patients with mild infections (n = 9) and patients with severe infections (n = 9)
and clinical data allowed us to correct for known underlying diseases. Additionally, outbreak isolates (n = 3) were
selected. Strains were analyzed on a DNA-DNA microarray for presence or absence of 281 genes covering marker
groups of genes related to pathogenicity, phages, antimicrobial resistance, fimbriae, mobility, serotype and
metabolism. Strains showed highly similar profiles when comparing virulence associated genes, but differences
between strains were detected in the prophage marker group. The Salmonella virulence plasmid was present in
72% of the strains, but presence or absence of the virulence plasmid did not correspond to disease symptoms. A
dendrogram clustered strains into four groups. Clustering confirmed DT104 as being a clonal phagetype. Clustering
of the remaining strains was mainly correlated to presence or absence of the virulence plasmid and mobile
elements such as transposons. Each of the four clusters in the tree represented an almost equal amount of strains
causing severe or mild symptoms of infection.
Conclusions: We investigated clinical significance of known virulence factors of Salmonella serotype Typhimurium
strains causing different disease symptoms, and conclude that the few detected differences in Salmonella serotype
Typhimurium do not affect outcome of human disease.
Background
Globally, Salmonella enterica subsp. enterica is one of
the leading food-borne pathogens. For example in 2006
in the United States, Salmonella enterica subsp. enterica
caused 45.808 registered cases of salmonellosis, corre-
sponding to an incidence of 15 cases/100,000 inhabi-
tants [1]. Furthermore the actual number of infections is
estimated to be 38 times higher [2]. In Denmark, there
were 1658 registered cases of salmonellosis (incidence of
30 cases/100,000 inhabitants) in 2006 [3]. Salmonella
serotype Typhimurium, denoted S. Typhimurium,
accounted for 17% of the salmonellosis cases in the
USA and 25% of the Danish cases [1,3]. The outcome of
human infection ranges from mild self-limiting diar-
rhoea to severe diarrhoea that requires hospitalization.
In rare cases, often among immunocompromised
patients, salmonellosis can be fatal.
Several factors in both the host and the bacteria influ-
ence the outcome of an infection. Clearly an important
aspect of human infection is the immune state of the
patient. It has been shown that immunocompromised
patients are more prone to develop a severe infection
[4]. Another important aspect of human infection is the
intestinal microbiota of the host. Ingestion of antibiotics
is known to affect the intestinal microbiota leaving the* Correspondence: evl@ssi.dk1Statens Serum Institut, Bacterial Typing, Artillerivej 5, DK-2300 Copenhagen
S, Denmark
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host more prone to infection and disease caused by S.
Typhimurium [5].
Significant bacterial factors for the outcome of infec-
tion are encoded by a wide range of genetic elements,
including plasmids, prophages and Salmonella Patho-
genicity Islands (SPIs). A total of 14 SPIs have been
described so far [6]. SPI-1 encodes type 3 secretion sys-
tem 1 (T3SS-1) that causes secretion and translocation
of a range of bacterial proteins to the host cell. SPI-2
encodes T3SS-2 that allows intracellular survival and
replication [7].
Different S. Typhimurium strains share more than
99% genomic content [8]. The detected variation within
S. Typhimurium is primarily represented by the pro-
phages in the genome [9]. Variation in phenotype has
also been demonstrated as there are different phagetypes
of S. Typhimurium strains, and some of them can even
show a high degree of variation in host adaptation [10].
Intra-serotype variability is also caused by the plasmids
carried by S. Typhimurium, in particular, the Salmonella
Virulence Plasmid (pSLT) which was observed more fre-
quently in the strains isolated from blood than the
strains isolated from faeces [11]. It has been proposed
that this plasmid is significant in the spreading of an
infectious strain from the intestine [12].
The recent development of microarray technology has
allowed an extensive screening of many S. Typhimurium
strains [13-15], but to our knowledge, no study has been
able to link the molecular data obtained by microarray
analysis of the strains to detailed epidemiological and
clinical patient data.
We analyzed a collection of S. Typhimurium strains
by DNA microarray analysis. These strains were selected
on the basis of a previous epidemiological study where
clinical data were obtained by means of patient inter-
views. The strains were selected from patients with mild
infections and from patients with severe infections, and
clinical data allowed us to correct for known underlying
diseases and patient age. Strains were analyzed for pre-
sence or absence of 281 genes covering marker groups
of genes related to pathogenicity, phages, antimicrobial
resistance, fimbriae, mobility, serotype, and metabolism.
We show that S. Typhimurium strains causing very dif-
ferent symptoms in patients had little genomic variation,
and the observed variation does not correlate to the
severity of disease.
Results
Subtyping
All strains were subtyped by Pulsed-field gel electro-
phoresis (PFGE), Multiple-locus variable-number of tan-
dem-repeat analysis (MLVA) and Multilocus sequence
typing (MLST). In general, the PFGE types of the strains
correspond to the phagetype. All of the phagetype DT12
strains had the PFGE 22 profile and five out of six
DT104 strains had the PFGE 14 profile. The remaining
phagetypes showed different PFGE profiles (see addi-
tional file 1: Xba I PFGE profiles of all isolates).
The MLVA types of the strains were all different. Loci
STTR-9 and STTR-3 were the most conserved alleles
and they had 1, 2 or 3 repeat units. STTR-5, STTR-6
and STTR-10 were all alleles with varying repeat units.
Some strains did not contain the STTR-10 allele at all,
corresponding well to the fact that these strains were
not carrying the pSLT (see additional file 2: Typing
results of all strains).
The Sequence types (ST) of the strains were primarily
ST19. Only three strains had other STs and these were
ST376, ST35 and ST34 (see additional file 2: Typing
results of all strains).
DNA microarray marker groups Resistance and
Serotyping
The DNA microarray included 49 probes that targeted
10 different resistance genes and some of their known
variants. The phenotypic resistance profiles all corre-
sponded to the results obtained by the array (see addi-
tional file 3: Microarray results of all markers). The
DNA microarray included 33 probes that target different
O-serogroups and H-antigens. The S. Typhimurium ser-
otype was confirmed by the array (see additional file 3:
Microarray results of all markers).
DNA microarray marker groups Metabolism, Prophage
and Mobility
The DNA microarray contained 20 probes targeting dif-
ferent genes in the metabolism marker group. All strains
on the array possessed 18 of the 20 metabolism genes.
The gene SEN4287, which has been observed in sero-
types S. Enteritidis, S. Dublin and S. Gallinarum and the
gene STY4221, which has been found in serotypes S.
Typhi and S. Paratyphi A, were not detected in any of
the S. Typhimurium strains.
The DNA microarray contained 10 probes targeting
different genes in the prophage marker group. Prophage
related genes showed different present/absent profiles in
different strains. All DT104 strains displayed identical
profiles within the prophage marker group. Only DT104
strains possessed the ORF84 marker. The prophage
genes sb10 and sb54 were present in all DT104 strains
and some other strains. The genes STY3672, STY3676
and STY4625 were present in both DT10 strains and
one of three RDNC strains. The remaining genes in the
prophage marker group were identically present/absent
in all strains (see additional file 3: Microarray results of
all markers).
The DNA microarray contained 57 probes targeting
different genes in the mobility marker group which also
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included plasmid incompatibility markers and IS-ele-
ment markers. The markers showed high variability in
the present/absent pattern among all strains. The varia-
bility correlated well with known properties of strains,
e.g. all strains lacking the pSLT, also lacked the gene
encoding the typical FIIA replicon of pSLT, and these
strains also lacked the traT gene that is encoded in
pSLT (see additional file 3: Microarray results of all
markers).
DNA microarray marker groups Pathogenicity and
Fimbrial
The pathogenicity marker group consisted of 87 mar-
kers and the strains had a highly similar pattern of pre-
sent/absent genes within this marker group. Only the
DT104 strains showed variation, as they lacked the gipA
gene encoded by the Gifsy-1 prophage but harboured
the two other genes encoded by Gifsy-1. The DT104
strains also possessed two other prophage-related genes
which no other strains possessed. All strains harboured
prophage Gifsy-2 and lacked prophages Gifsy-3 and
Fels-1. Five strains of five different phagetypes lacked
the pSLT and, therefore, lacked the virulence genes
encoded in the plasmid. In total, 72% of the strains in
this study carried the pSLT. The same percentage is
observed when comparing all of the S. Typhimurium
strains detected in Denmark between 2005 and 2009
(data not shown).
The SPI-1 to SPI-5 were present and SPI-7 was absent
in all strains (Fig. 1).
The DNA microarray contained 22 probes targeting
different genes in the fimbrial marker group. All strains
showed identical patterns within this marker group,
except for the pefA gene which is encoded in the pSLT.
One strain carrying the pSLT did not show a positive
reaction in the pefA probe (Fig. 1).
Clustering of strains
The microarray analysis clustered the strains into four
major branches in a dendrogram (Fig. 2). The dendro-
gram is calculated from all markers except the resistance
and serotyping markers as these could create a bias in
the analysis. Cluster A had a depth of 96.1% and con-
tained most of the DT12 strains but also other phage-
types. The strains in cluster A all harboured the pSLT,
and all seven strains were fully sensitive to antimicrobial
agents (see additional file 2: Typing results of all
strains). In cluster A, two strains represented severe
infection, four strains represented mild infection, and
there was one outbreak strain. Cluster B had a depth of
98.6% and contained all six DT104 strains, which all
harboured the pSLT. Two of the DT104 strains were
fully susceptible to antimicrobial agents. In cluster B,
two strains represented severe infection, two strains
Figure 1 Microarray results of virulence associated markers.
Markers are listed according to genomic location or function. A
grey box indicates that the marker is present, and a white box
indicates that the marker is absent.
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represented mild infection, and additionally there were
two outbreak strains.
Cluster C had a depth of 95.2% and contained only
three strains of three different phagetypes. All of the
three strains carried the pSLT and showed resistance to
at least four antimicrobial agents. The strains in cluster
C branch off separately as they possess more genes from
the mobility marker group which includes transposases.
In cluster C, two strains represented severe infection
and one strain represented mild infection. Cluster D had
a depth of 97.2% and contained five strains of different
phagetypes, including a DT12 strain, but none of the
strains harboured the pSLT. One strain in cluster D
showed resistance to three antimicrobial agents. In clus-
ter D, three strains represented severe infection while
two strains represented mild infection. In conclusion,
strains causing severe and mild infection were repre-
sented equally across the dendrogram (Fig. 2).
Discussion
A collection of S. Typhimurium strains were analyzed
and compared by the use of a microarray designed for
characterization of Salmonella. The array consisted of
281 markers covering marker groups of genes related to
pathogenicity, phages, antimicrobial resistance, fimbriae,
mobility, serotype, and metabolism. Extensive back-
ground knowledge of patients regarding symptoms and
underlying diseases enabled us to compare strains caus-
ing mild symptoms to strains causing severe symptoms.
Initial subtyping of the strains was performed using
MLST and MLVA. These two methods target different
parts of the chromosome and areas with different
genetic variability, leading to differences in the discrimi-
natory power of the methods. MLVA methods are gen-
erally high-discriminatory typing methods developed for
outbreak investigations, and the S. Typhimurium MLVA
method used in this study was specifically developed to
differentiate the highly similar DT104 clone [16]. This
method is based on highly variable repeat regions on
the chromosome and on a plasmid. MLST is developed
to estimate long term development and is based on con-
served housekeeping genes with minimal variation [17].
Most strains in this study belonged to ST19, except for
three strains with different STs. The difference between
ST19 and each of the other STs was a single nucleotide
change in one allele, so the similarity of the strains was
high as expected with MLST. The strains all had differ-
ent MLVA profiles, corresponding well with the fact
Figure 2 UPGMA dendrogram. UPGMA dendrogram calculated on microarray results as binary coefficients by simple matching, markers for
serotype and resistance are not included. Each marker is listed along the horizontal top of the dendrogram, and a black line in the figure
represents a positive hybridisation and thus gene present. Four clusters indicated by letters A-D. M = Mild symptoms, S = Severe symptoms, O =
Outbreak.
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that MLVA is a more discriminatory typing method and
the strains were selected to be epidemiologically
unrelated.
The strains were tested for antimicrobial resistance
and eight of 21 strains showed resistance to three or
more antimicrobial agents. Three strains from the group
with mild symptoms, four strains from the group with
severe symptoms, and a single outbreak strain showed
resistance to antimicrobial agents. The resistance pattern
did not correlate with the severity of disease in patients.
The lack of increased virulence of resistant strains has
previously been shown in DT104 strains [18,19]. An
American study described that humans who ingested
antimicrobials are more prone to get a subsequent infec-
tion with a resistant S. Typhimurium strain [20]. Two of
the patients included in our study were administered
antimicrobials within a month before onset of the S.
Typhimurium infection, one patient was in the group
with severe symptoms and the other patient was in the
group with mild symptoms. Both infections were caused
by resistant S. Typhimurium strains.
Differences between the S. Typhimurium strains were
detected in the prophage marker group. The DT104
strains were different as seen by detection of the ORF84
marker, previously shown to be present primarily in
DT104 strains [21]. The Salmonella prophage ST64B
(sb10 and sb54) was detected in different phagetypes in
this study, but notably this prophage is present in all
DT104 strains, and these observations corresponded to
previous findings [22]. Other genes showing variability
within the prophage marker group were the S. Typhi
specific genes STY3672, STY3676 and STY4625. The
markers of these genes were detected in three S. Typhi-
murium strains. The occurrence of these genes could be
explained by lacking specificity of the probe, or by point
mutations in the S. Typhimurium strains leading to
cross-hybridization. Prophages are known to contribute
to virulence in mice [23] but presence or absence of
prophages does not correlate with any differences in
symptoms caused by strains in our study investigating
strains isolated from humans.
The mobility marker group also displayed variation
between strains, but most variation related to incompat-
ibility groups of plasmids and probes encoding transpo-
sons. The variation did not correspond to any
phagetypes or disease symptoms.
The strains showed highly similar profiles when com-
paring the virulence associated genes. Some variation
was detected between other phagetypes and the DT104
strains which were the only strains containing the hldD
gene and the irsA gene, but these genes have previously
been shown to be specific for the DT104 phagetype
[24]. Also the Gifsy-1 encoded genes showed variation
between other phagetypes and the DT104 strains, as the
DT104 strains lacked one of three Gifsy-1 encoded
genes present on the array. The gene lacking in our
DT104 strains is consistent with an observation made
recently in a study comparing the genome sequence of a
DT104 strain to a S. Typhimurium LT2 strain [25]. The
study observes a prophage sequence in DT104 which
only shows partly homology to the Gifsy-1 prophage
sequence. All other strains in our study possessed the
Gifsy-1 prophage. The SPI-1 to SPI-5 were present in all
strains but the SPI-7 was absent. SPI-7 was initially
reported in a S. Typhi [26], and similar islands were
detected in S. Dublin and S. Paratyphi C [27]. The pSLT
is another important virulence marker. In an American
study, pSLT was shown to be present in 76% of strains
isolated from blood compared to 42% of strains isolated
from faeces [11], however, in the present study the viru-
lence plasmid was present in 72% of the strains, even
though the strains were all isolated from faeces and
some strains caused very mild disease symptoms. The
selected S. Typhimurium strains are representative for
the Danish S. Typhimurium population regarding the
presence of pSLT, as 72% of all Danish S. Typhimurium
isolates from 2005 until 2009 carried the plasmid. Out
of five strains lacking the pSLT, three had caused severe
symptoms. Interestingly, strains can cause infection with
severe symptoms even if they lack the plasmid. Further-
more, strains can carry the pSLT and only cause infec-
tion with mild symptoms. In this study, the presence or
absence of pSLT did not correspond to any phagetypes
or disease symptoms.
The dendrogram calculated on the basis of the array
results showed clustering of the strains into four
groups. The clustering confirmed DT104 as being a
clonal phagetype, but a number of probes were also
designed to target only DT104 strains, and that might
emphasize the separate clustering of this phagetype.
The clustering of the remaining groups was mainly
correlated to the presence or absence of the pSLT and
other mobile elements such as transposons. The four
clusters in the tree represented an almost equal
amount of strains causing severe or mild symptoms of
S. Typhimurium infections.
The probes on the array were designed primarily on
basis of the S. Typhimurium LT2 sequence, but also
some additional known genes from other serotypes such
as S. Enteritidis and S. Typhi. The presence or absence
of additional S. Typhimurium genes, which are not pre-
sent in the LT2 sequence, could not be assessed in this
study. It is possible that the presence or absence of such
genes, not present in LT2, are responsible for the
observed differences in the patient symptoms. Although
this is not likely, as recent publications of sequenced S.
Typhimurium strains showed few gene differences to
the LT2 sequenced strain [28,29].
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Conclusion
We investigated a collection of Salmonella strains for
the presence of a wide range of known virulence genes,
and detected no significant difference in the presence of
these genes. The investigated strains were carefully
selected, based on epidemiological data, to represent
strains causing severe symptoms of disease and strains
causing mild symptoms of disease. Although the investi-
gated strains had different genomic contents, this study
found no evidence of a correlation between the genomic
contents of the S. Typhimurium strains and the symp-
toms they caused in human cases of salmonellosis.
Based on the results of this study, an idea which imme-
diately suggests itself is that the factors and defence
mechanisms of the host immune system may play a fun-
damental role in the different outcomes of infection.
Methods
Patient interviews
Data for the present study was obtained from a prospec-
tive cohort study carried out in Denmark from Septem-
ber 2001 to December 2002 [30]. Cases were patients
with a culture-confirmed S. Typhimurium infection,
identified by the examination of samples submitted to
Statens Serum Institut (SSI) from hospitals and general
practitioners. Patients were invited to participate by
their own physicians or the relevant hospital depart-
ment. Individuals who agreed to participate were mailed
a questionnaire and asked to complete the questionnaire
immediately. Data was collected by a computer-assisted
telephone interviewing system (CATI) whilst the sub-
jects were looking at their questionnaire. This method
facilitated data collection and allowed standardized
probing about relevant exposures and outcomes. Data
collected included information on clinical symptoms,
treatment, medications (including antimicrobials) from
one month before infection to one month after, underly-
ing illnesses, foreign travel during the two weeks prior
to inclusion and basic socioeconomic variables i.e. edu-
cation, occupation and household income. Cases were
excluded for the following reasons: an earlier history of
Salmonella infection within six month prior to onset of
the current infection, lack of communication skills in
Danish, or if the patient’s health care provider deemed
the patient unable to complete interview due to an
impaired mental state. A parent was interviewed if the
patient was under 15 years of age and if the patients
were between 15 and 18 years of age they could be
interviewed - subject to parental approval. This study
was reported to The Danish Data Protection Agency
and has been approved by the regional scientific ethical
committee of Copenhagen and Frederiksberg Municipal-
ity (KEF 01-031/01).
Selection of strains
Faecal strains of S. Typhimurium were chosen based on
the previously described patient interviews. Strains from
patients over the age of 65 years and strains from
patients with known underlying diseases were not
included in this study. The patients were sorted accord-
ing to hospitalization data and fever. Two groups were
then established: a severe infection group with patients
who were hospitalized due to their S. Typhimurium
infection and also had a fever; and a mild infection
group with patients who were not hospitalized and did
not have a fever. From each of these groups nine strains
were selected, aiming to represent the same phagetypes
in each group (Table 1). The phagetype distribution
observed within all strains from the interviewed patients,
not including the patients with known underlying dis-
ease, correlated to the overall distribution of all human
S. Typhimurium strains in Denmark in 2001 and 2002.
A pattern of specific phagetypes relating to specific
symptoms was not observed within the entire interview
material (data not shown). Of the nine hospitalized
patients, four had bloody stools. Furthermore, three out-
break strains were included in the study, representing
strains with known high virulence potential. All faecal
samples received at SSI in Denmark are screened for
double infection with frequently occurring intestinal
Table 1 Isolate information and degree of disease
symptoms.
Isolate nr Phage
type
Patient
age
Year of
isolation
Disease
symptoms
0210F37188 3 39 2002 Mild
0110H11581 10 38 2001 Mild
0202F44678 12 30 2002 Mild
0205R4381 12 41 2002 Mild
0111H24126 104 62 2001 Mild
0210H31581 104 14 2002 Mild
0110F7002 120 63 2001 Mild
0209H16582 120 0 2002 Mild
0211F40143 RDNC 1 2002 Mild
0201H32554 10 3 2002 Severe
0112F33212 12 47 2001 Severe
0207T9764 12 11 2002 Severe
0112F28702 104 20 2001 Severe
0110R3988 104a 36 2001 Severe
0210M16322 170 19 2002 Severe
0208F10996 193 9 2002 Severe
0111M12249 RDNC 12 2001 Severe
0207M72344 RDNC 16 2002 Severe
0506H32341 12 53 2005 Outbreak
0509R6852 104 58 2005 Outbreak
0511R7026 104 2 2005 Outbreak
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pathogens such as Campylobacter, Shigella, Yersinia and
others. All strains used in this study were confirmed as
originating from a single-organism infection.
Serotyping
All strains were previously serotyped at SSI according to
the White-Kauffmann-Le Minor scheme [31] by aggluti-
nation with O- and H-antigen specific sera (SSI Diag-
nostika, Hillerød, Denmark). All strains belonged to
Salmonella enterica serotype Typhimurium.
Antimicrobial susceptibility testing
Susceptibility to a standard panel of antimicrobial agents
http://www.danmap.org was determined by microbroth
dilution and interpreted according to Clinical and
Laboratory Standards Institute guidelines [32], except
for ciprofloxacin (≥0.125 μg/mL was used as
breakpoint).
Phage typing
Phage typing was performed by the National Food Insti-
tute, Technical University of Denmark according to the
phage typing scheme developed by Callow [33] and
extended by Anderson et al. [34]. Strains that react with
phages, but have a profile not included in the phage typ-
ing scheme, are denoted Reaction Does Not Conform
(RDNC).
DNA microarray
The DNA microarray used in this study was previously
described [35]. A set of 281 gene-specific 57-60 mer oli-
gonucleotide probes were designed using the program
Array Designer 4.1 (Premier Biosoft, Palo Alto, CA,
USA). The oligonucleotides were spotted on glass slides
using a QArray Mini Arrayer (Genetix, New Milton,
UK). Hybridized spots were visualized in a GenePix
4000B laser scanner (Axon, Foster City, CA). Each oligo-
nucleotide allows the detection of the presence or
absence of a characteristic sequence previously
described in Salmonella. The microarray used gives no
information on the location of a gene or target sequence
and can only score its presence or absence. Uncertain
array results were resolved by PCR using primers
described previously [35].
Data analysis
Analysis of the DNA microarray data was performed as
previously described [35]. A comparison was made by
importing array values, gene present or absent, into Bio-
Numerics 5.1 (Applied Maths, Sint-Martens-Latem,
Belgium) as character data. An Unweighted Pair Group
Method with Arithmetic mean (UPGMA) dendrogram
(Fig. 2) was calculated by simple matching of binary
coefficients on the basis of a geneset consisting of all
genes from the array except the serotyping markers and
the resistance markers.
Multiple-locus variable-number of tandem-repeat analysis
(MLVA)
MLVA was performed as described previously [36] to
ensure that the strains were likely to be epidemiologi-
cally unrelated. The MLVA repeats were calculated and
named according to the method described recently [37].
Pulsed-field gel electrophoresis (PFGE)
PFGE was carried out with XbaI restriction enzyme
according to the Pulse-Net protocol [38], gels were ana-
lyzed in BioNumerics 5.1, and profiles were assigned by
comparison to a database with known Danish profiles
(see additional file 1: Xba I PFGE profiles of all isolates).
Sequence typing
Multilocus sequence typing (MLST) was carried out as
previously described [39] and the alleles and the
sequence types were assigned according to the MLST
scheme on http://mlst.ucc.ie/mlst/mlst/dbs/Senterica/.
Additional file 1: PFGE profiles. Xba I PFGE profiles of all isolates
Additional file 2: Typing results of all strains
Additional file 3: Microarray results of all markers. Markers are listed
alphabetically within marker groups. A grey box indicates the marker
being present and a white box indicates the marker being absent.
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